Exousia Bio (LMMY) Payables (2022 - 2025)

Exousia Bio has disclosed Payables across 4 years of filings, most recently posting $212302.0 for Q4 2025.

• Payables for Q4 2025 came in at $212302.0, changed N/A year-over-year; the trailing twelve-month figure through Nov 2025 was $212302.0 (changed N/A YoY), and the FY2024 annual result was $29000.0, changed 0.0% from the prior year.
• Payables came in at $212302.0 for Q4 2025 at Exousia Bio, up from $29000.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $212302.0 in Q4 2025 to a low of $29000.0 in Q2 2022.
• The 4-year median for Payables is $29000.0 (2022), against an average of $49366.9.
• Peak annual rise in Payables reached 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
• Exousia Bio's Payables stood at $29000.0 in 2022, then changed by 0.0% to $29000.0 in 2023, then changed by 0.0% to $29000.0 in 2024, then soared by 632.08% to $212302.0 in 2025.
• The last three Payables figures came in at $212302.0 (Q4 2025), $29000.0 (Q3 2024), and $29000.0 (Q2 2024), per Business Quant data.